Fangda represented InnoScience in its appro. RMB3 billion series D financing
Tell others about this press release
The press releases published in this section have been uploaded by law firms. Their content has not been appraised or edited by Law.asia, and no responsibility is taken for the accuracy of the information they contain or any misrepresentation therein. For our independent editorial content, please visit our homepage.
Fangda Partners represented InnoScience (Suzhou) Technology Co., Ltd. (“InnoScience”) in its series D financing, which was led by TI-Capital and the co-investors include but not limited to ADDOR Capital, Haitong Innovation, China-Belgium Direct Equity Investment Fund, SAIF Eagle Fund and CMS Investment. The deal was consummated in February, 2022 and announced on February 16, 2022, involving an aggregated transaction amount of approximately RMB3 billion. The Fangda team on this deal was led by corporate partners Xueyan JIANG and Silvia GONG, and the team members include Shawn Liu, Murphy Li, Eunice Dai, Mengyu Zhu, Ellyn Ai, Viola Jiang, Xiu Zhang, Minhong Cai and Chaoqing Li. Fangda participated in the whole process of this deal, including the vendor legal due diligence, drafting and negotiation of the transaction documents and the closing process. Innoscience is a world-leading Integrated Device Manufacturer (IDM) focused on the third generation semiconductor GaN-on-Si technology, which owns the first and largest 8-inch GaN-on-Si wafer production line in the world.
Join our mailing list for legal news and alerts
Sign up